1. New vaccine technology may be put to test with COVID-19 — FDA rejects Merck's 6-week Keytruda dosing schedule — Blood disorder startup Imara files for $86M IPO — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Nephron Pharmaceuticals

Anonymous board for Nephron Pharmaceuticals


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    14
    Views:
    9,446
  2. Anonymous
    Replies:
    4
    Views:
    8,621
  3. anonymous
    Replies:
    21
    Views:
    9,643
  4. anonymous
    Replies:
    33
    Views:
    16,630
  5. Anonymous
    Replies:
    49
    Views:
    20,549
  6. Anonymous
    Replies:
    34
    Views:
    15,312
  7. Smarty Pants
    Replies:
    16
    Views:
    11,666
  8. Anonymous
    Replies:
    25
    Views:
    11,105
  9. Anonymous
    Replies:
    15
    Views:
    10,477
  10. anonymous
    Replies:
    152
    Views:
    42,851
  11. Anonymous
    Replies:
    43
    Views:
    18,471
  12. anonymous
    Replies:
    40
    Views:
    14,074
  13. Anonymous
    Replies:
    6
    Views:
    5,394
  14. nephronymous
    Replies:
    8
    Views:
    7,280
  15. Anonymous
    Replies:
    8
    Views:
    7,756
  16. Anonymous
    Replies:
    2
    Views:
    3,167
  17. Anonymous
    Replies:
    47
    Views:
    23,325
  18. Anonymous
    Replies:
    16
    Views:
    7,251
  19. Anonymous
    Replies:
    1
    Views:
    3,417
  20. Anonymous
    Replies:
    14
    Views:
    13,444

Thread Display Options

Loading...